Back to Screener

Healthcare

Artivion, Inc.(CRY)

Live Price

Offline

$21.35

-1.49% today

Window Change

-14.46%

Window

Apr 28, 2026 โ†’ Jun 22, 2026

Market Cap
$1.74B
Revenue Growth
+13.6%
EPS Growth
+168.8%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 38 bars ยท Apr 28, 2026 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Artivion, Inc. (CRY) is a Healthcare stock with a market cap of $1.74B. The stock last traded around $21.35 and down 14.5% across the available one-year price window (Apr 28, 2026 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of +13.6%, EPS growth of +168.8%, a dividend yield of 0.0%. What stands out right now is revenue +13.6%, EPS +168.8%, free cash flow -92.4% with operating margin 6.9% and ROIC 2.5%. Valuation already assumes a fairly strong business story at P/E 174.8 and price/sales 3.9. Stock Foundry combines CRY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+13.6% vs +7.6% peer median

Operating Margin

Below sector median

+6.9% vs +19.4% peer median

P/E

Above sector median

174.8 vs 36.3 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report was closer to in-line

2022 was reported on Feb 9, 2022 with revenue ahead of estimates by +1.4%.

The operating story is still moving forward

Revenue is running at +13.6% and EPS at +168.8%, with operating margin around 6.9%.

Benchmark Edge

CRY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CRY

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CRY Max Drawdown

-17.66%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CRY and SPY.

Calendar-year return history is still loading or unavailable.
AR

Company Overview

Artivion, Inc.

Last Updated
May 8, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
174.8
EV/EBITDA
33.4
Price/Sales
3.9
Price/Book
3.8

Growth

Revenue
+13.6%
EPS
+168.8%
Free Cash Flow
-92.4%

Profitability

Gross Margin
63.6%
Operating Margin
6.9%
Net Margin
2.2%
ROE
2.4%
ROIC
2.5%

Balance Sheet

Debt/Equity
0.65
Current Ratio
2.99

Earnings Reports

๐Ÿ“… Last reportedFeb 9, 2022
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Feb 9, 22
-0.51
Est โ€”
โ€”
79394.0B
Est 78260.0B
+1.4%
โ€”
Nov 4, 21
โœ“
0.26
Est 0.02
+1400.3%
72207.0B
Est 72400.0B
-0.3%
โ€”
Jul 29, 21
โœ—
-0.06
Est -0.05
-20.0%
76148.0B
Est 70970.0B
+7.3%
โ€”
Apr 29, 21
โœ“
-0.08
Est -0.09
+11.1%
71087.0B
Est 62980.0B
+12.9%
โ€”
Feb 11, 21
โœ“
0.20
Est 0.03
+566.7%
67896.0B
Est 66530.0B
+2.0%
โ€”
Nov 4, 20
โœ“
0.13
Est 0.03
+388.9%
65131.0B
Est 14791.4B
+340.3%
โ€”
Jul 30, 20
โœ“
-0.02
Est -0.14
+85.7%
53771.0B
Est 376397.0B
-85.7%
โ€”
Apr 30, 20
โœ—
-0.08
Est -0.01
-500.1%
66429.0B
Est 16607.3B
+300.0%
โ€”
Feb 13, 20
โœ“
0.10
Est 0.08
+25.0%
69697.0B
Est 55757.6B
+25.0%
โ€”
Oct 30, 19
โ€”
0.06
Est 0.06
0.0%
67881.0B
Est 67881.0B
0.0%
โ€”
Jul 30, 19
โœ“
0.11
Est 0.07
+57.1%
71139.0B
Est 45270.3B
+57.1%
โ€”
Apr 30, 19
โ€”
0.04
Est 0.04
0.0%
67505.0B
Est 67505.0B
0.0%
โ€”
Feb 14, 19
โœ—
0.05
Est 0.11
-54.5%
67799.0B
Est 149157.8B
-54.5%
โ€”
Oct 31, 18
โœ“
0.08
Est 0.07
+14.3%
64598.0B
Est 56525.0B
+14.3%
โ€”
Aug 6, 18
โœ“
0.10
Est 0.07
+42.9%
68496.0B
Est 47950.0B
+42.9%
โ€”
May 2, 18
โ€”
0.02
Est 0.02
0.0%
61948.0B
Est 61950.0B
0.0%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks